Q&A: Behind the Marburg Virus Outbreak in Rwanda

Published on May 28, 2025

In response to Rwanda’s first Marburg virus outbreak in September 2024, Sabin quickly delivered 2,700 vaccine doses to support a clinical trial for frontline workers. The outbreak was contained by December, highlighting the impact of rapid response and collaboration. To learn more, click the link below!

Read More! 
 
 
Other news

Sabin Begins Marburg Vaccine Trial in U.S.

May 28, 2025
Sabin has launched a Phase 2 Marburg virus vaccine trial in the U.S., building on studies in Kenya and Uganda. The trial will assess safety and immune response in 200 adults across four U.S. sites. Read more about this critical step toward protecting against future outbreaks.

WHO World Immunization Week Resources

May 28, 2025
From April 24–30, we join the global community in celebrating World Immunization Week under the theme “Immunization for All is Humanly Possible.” Over the past 50 years, vaccines have saved more than 154 million lives – that’s 6 lives every minute.Vaccines are one of the greatest achievements in global health, accounting for 40% of the improvement in infant survival. But our work isn’t done. The f